{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T15:56:49Z","timestamp":1765727809243,"version":"3.41.0"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2016,8,4]],"date-time":"2016-08-04T00:00:00Z","timestamp":1470268800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100004248","name":"Psoriasis and Psoriatic Arthritis Alliance","doi-asserted-by":"publisher","award":["1118192"],"award-info":[{"award-number":["1118192"]}],"id":[{"id":"10.13039\/501100004248","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,3,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The majority of patients with psoriasis have mild to moderate disease which can be managed in primary care with topical therapies. The supportive role of pharmacists for patients with long-term dermatological conditions is largely unknown.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To assess the impact of an educational intervention delivered by community pharmacists to improve self-management for people with psoriasis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>The study involved a pre- and post-intervention design. Seven community pharmacies were selected based on their location (urban, rural etc.) and the pharmacists recruited via local comprehensive research networks. Patients with mild to moderate psoriasis were recruited either opportunistically or via a letter of invite by pharmacists who undertook a face-to-face consultation with one follow-up visit after 6 weeks. The primary outcome was the change in person-centred dermatology self-care index (PEDESI) score and secondary outcomes were the self-assessed psoriasis and severity index (SAPASI), measuring disease severity and the dermatology quality of life index (DLQI).<\/jats:p><\/jats:sec><jats:sec><jats:title>Key findings<\/jats:title><jats:p>A total of 47 patients were recruited. At 6 weeks, 42\/47 (89.3%) patients completed the follow-up consultation. There was a significant increase in mean PEDESI scores (25.15 versus 17.78, P &amp;lt; 0.001) at 6 weeks compared to baseline. Similarly, SAPASI (11.60 versus 7.74, P &amp;lt; 0.001) and DLQI (7.21 versus 4.14, P &amp;lt; 0.001) scores improved significantly.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Pharmacist-assisted support for patients with psoriasis improved knowledge, reduced disease severity and the impact on quality of life. These results suggest that community pharmacists might have an important role to play in facilitating self-management for patients with psoriasis.<\/jats:p><\/jats:sec>","DOI":"10.1111\/ijpp.12298","type":"journal-article","created":{"date-parts":[[2016,8,4]],"date-time":"2016-08-04T09:35:06Z","timestamp":1470303306000},"page":"140-146","source":"Crossref","is-referenced-by-count":14,"title":["The role of community pharmacists in supporting self-management in patients with psoriasis"],"prefix":"10.1093","volume":"25","author":[{"given":"Rod","family":"Tucker","sequence":"first","affiliation":[{"name":"School of Pharmacy & Life Sciences, Robert Gordon University, Aberdeen, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek","family":"Stewart","sequence":"additional","affiliation":[{"name":"School of Pharmacy & Life Sciences, Robert Gordon University, Aberdeen, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2016,8,4]]},"reference":[{"volume-title":"About Psoriasis","year":"2012","author":"Psoriasis Association","key":"2021031318504839800_ijpp12298-bib-0001"},{"issue":"Suppl 2","key":"2021031318504839800_ijpp12298-bib-0002","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/ard.2004.033217","article-title":"Psoriasis: epidemiology, clinical features, and quality of life","volume":"64","author":"Langley","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"2021031318504839800_ijpp12298-bib-0003","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2165\/00128071-200506060-00005","article-title":"The psychosocial burden of psoriasis","volume":"6","author":"Kimball","year":"2005","journal-title":"Am J Clin Dermatol"},{"key":"2021031318504839800_ijpp12298-bib-0004","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1177\/1049732306297674","article-title":"Marked by visibility of psoriasis in everyday life","volume":"17","author":"Uttjek","year":"2007","journal-title":"Qual Health Res"},{"key":"2021031318504839800_ijpp12298-bib-0005","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1365-2133.2006.07354.x","article-title":"The impact of psoriasis guidelines on appropriateness of referral from primary to secondary care: a randomized controlled trial","volume":"155","author":"Griffiths","year":"2006","journal-title":"Br J Dermatol"},{"key":"2021031318504839800_ijpp12298-bib-0006","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jaad.2008.03.045","article-title":"One in three prescriptions are never redeemed: primary non adherence in an outpatient clinic","volume":"59","author":"Storm","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"2021031318504839800_ijpp12298-bib-0007","first-page":"581","article-title":"Patients with psoriasis and their compliance with medication","volume":"41","author":"Richards","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"2021031318504839800_ijpp12298-bib-0008","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/j.1365-2133.2010.09916.x","article-title":"Self-management experiences in adults with mild to moderate psoriasis: an exploratory study and implications for improved support","volume":"163","author":"Ersser","year":"2010","journal-title":"Br J Dermatol"},{"key":"2021031318504839800_ijpp12298-bib-0009","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1365-2133.2012.11217.x","article-title":"Recognition of need in health care consultations: a qualitative study of people with psoriasis","volume":"2013","author":"Nelson","year":"2013","journal-title":"Br J Dermatol"},{"key":"2021031318504839800_ijpp12298-bib-0010","first-page":"1","article-title":"Conversations on psoriasis \u2013 what patients want and what physicians can provide: a qualitative look at patient and physician expectations","volume":"204","author":"Uhlenhake","year":"2009","journal-title":"J Dermatolog Treat"},{"key":"2021031318504839800_ijpp12298-bib-0011","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/1471-2296-14-158","article-title":"\u2018On the surface\u2019: a qualitative study of GPs\u2019 and patients\u2019 perspectives on psoriasis","volume":"14","author":"Nelson","year":"2013","journal-title":"BMC Fam Pract"},{"volume-title":"Psoriasis: assessment and management, CG 153","key":"2021031318504839800_ijpp12298-bib-0012"},{"key":"2021031318504839800_ijpp12298-bib-0013","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2340\/00015555-1022","article-title":"Patient education in chronic skin diseases: a systematic review","volume":"91","author":"de Bes","year":"2011","journal-title":"Acta Derm Venereol"},{"key":"2021031318504839800_ijpp12298-bib-0014","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.pec.2013.10.005","article-title":"Limited evidence of the effects of patient education and self-management interventions in psoriasis patients: a systematic review","volume":"94","author":"Larsen","year":"2014","journal-title":"Patient Educ Couns"},{"volume-title":"Pharmacy in England: building on strengths\u2013delivering the future","year":"2008","author":"Department of Health","key":"2021031318504839800_ijpp12298-bib-0015"},{"key":"2021031318504839800_ijpp12298-bib-0016","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s11096-015-0137-9","article-title":"Effectiveness of clinical pharmacy services: an overview of systematic reviews (2000-2010)","volume":"37","author":"Rotta","year":"2015","journal-title":"Int J Clin Pharm"},{"key":"2021031318504839800_ijpp12298-bib-0017","first-page":"319","article-title":"A pilot study of a community pharmacy intervention to promote the effective use of emollients in childhood eczema","volume":"278","author":"Carr","year":"2007","journal-title":"Pharm J"},{"key":"2021031318504839800_ijpp12298-bib-0018","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1001\/archdermatol.2012.1892","article-title":"The person-centered dermatology self-care index: a tool to measure education and support needs of patients with long-term skin conditions","volume":"148","author":"Cowdell","year":"2012","journal-title":"Arch Dermatol"},{"key":"2021031318504839800_ijpp12298-bib-0019","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1346-8138.1999.tb03458.x","article-title":"The SAPASI is valid and responsive to psoriasis disease severity changes in a multi-center clinical trial","volume":"26","author":"Fleischer","year":"1999","journal-title":"J Dermatol"},{"volume-title":"The Dermatology Quality of Life Index","key":"2021031318504839800_ijpp12298-bib-0020"},{"key":"2021031318504839800_ijpp12298-bib-0021","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000365390","article-title":"Determining the minimal clinically important difference and responsiveness of the dermatology life quality index (DLQI): further data","volume":"230","author":"Basra","year":"2015","journal-title":"Dermatology"},{"issue":"Suppl (R36)","key":"2021031318504839800_ijpp12298-bib-0022","article-title":"Investigating the contribution of community pharmacists in meeting the needs of patients with atopic eczema, in collaboration with GPs","volume":"13","author":"Tinkler","year":"2005","journal-title":"Int J Pharm Pract"},{"issue":"Suppl4","key":"2021031318504839800_ijpp12298-bib-0023","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1468-3083.2011.04060.x","article-title":"Maximizing patient adherence for optimal outcomes in psoriasis","volume":"25","author":"Bewley","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"volume-title":"Medicines Use Review","key":"2021031318504839800_ijpp12298-bib-0024"}],"container-title":["International Journal of Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fijpp.12298","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fijpp.12298","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/ijpp\/article-pdf\/25\/2\/140\/36595837\/ijpp12298.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ijpp\/article-pdf\/25\/2\/140\/36595837\/ijpp12298.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T12:31:57Z","timestamp":1749040317000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ijpp\/article\/25\/2\/140\/6092917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,4]]},"references-count":24,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,8,4]]},"published-print":{"date-parts":[[2017,3,8]]}},"URL":"https:\/\/doi.org\/10.1111\/ijpp.12298","relation":{},"ISSN":["0961-7671","2042-7174"],"issn-type":[{"type":"print","value":"0961-7671"},{"type":"electronic","value":"2042-7174"}],"subject":[],"published-other":{"date-parts":[[2017,4]]},"published":{"date-parts":[[2016,8,4]]}}}